Market capitalization | €6.38b |
Enterprise Value | €6.41b |
P/E (TTM) P/E ratio | 70.91 |
EV/FCF (TTM) EV/FCF | 71.21 |
P/B ratio (TTM) P/B ratio | 3.38 |
Dividend yield | 0.68% |
Last dividend (FY24) | €0.97 |
Revenue growth (TTM) Revenue growth | -100.00% |
Revenue (TTM) Revenue | €0.00 |
As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.
2 Analysts have issued a Financière De Tubize forecast:
2 Analysts have issued a Financière De Tubize forecast:
Jun '24 |
+/-
%
|
||
Revenue | - - |
-
|
|
Gross Profit | - - |
-
|
|
EBITDA | -1.78 -1.78 |
16%
16%
|
EBIT (Operating Income) EBIT | -1.78 -1.78 |
16%
16%
|
Net Profit | 90 90 |
183%
183%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Financiere de Tubize SA is a holding company, which engages in investing in biopharmaceuticals industry. The company was founded on June 30, 1928 and is headquartered in Brussels, Belgium.
Head office | Belgium |
CEO | Anne-Sophe Pijcke |
Founded | 1928 |
Website | www.financiere-tubize.be |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.